(Q44153168)

30 November 2017

Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers (English)

1 reference

30 November 2017

1 reference

L M Cass

1

1 reference

30 November 2017

J Brown

2

1 reference

30 November 2017

M Pickford

3

1 reference

30 November 2017

S Fayinka

4

1 reference

30 November 2017

S P Newman

5

1 reference

30 November 2017

C J Johansson

6

1 reference

30 November 2017

A Bye

7

1 reference

30 November 2017

1 January 1999

1 reference

Clinical Pharmacokinetics

30 November 2017

1 reference

30 November 2017

36 Suppl 1

1 reference

30 November 2017

21-31

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199936001-00003

30 November 2017

0 references

cites work

The behavior and significance of slow-binding enzyme inhibitors

1 reference

12 December 2020

Respiratory mucins: identification of core proteins and glycoforms

1 reference

12 December 2020

Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung

1 reference

12 December 2020

A technique for the absolute measurement of activity using a gamma camera and computer

1 reference

12 December 2020

Airway surface liquid thickness as a function of lung volume in small airways of the guinea pig

1 reference

12 December 2020

Pressurised aerosol deposition in the human lung with and without an "open" spacer device

1 reference

12 December 2020

2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus

1 reference

12 December 2020

How well do in vitro particle size measurements predict drug delivery in vivo?

1 reference

12 December 2020

The specificity of viral sialidases. The use of oligosaccharide substrates to probe enzymic characteristics and strain-specific differences

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020

Scintigraphic assessment of therapeutic aerosols

1 reference

12 December 2020

Characteristics of radiolabelled versus unlabelled inhaler formulations

1 reference

12 December 2020

10.2165/00003088-199936001-00003

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference